B

Broncus Holding Corp
HKEX:2216

Watchlist Manager
Broncus Holding Corp
HKEX:2216
Watchlist
Price: 0.46 HKD -1.08% Market Closed
Market Cap: 242.5m HKD
Have any thoughts about
Broncus Holding Corp?
Write Note

Broncus Holding Corp
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Broncus Holding Corp
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
B
Broncus Holding Corp
HKEX:2216
Net Income (Common)
-$28.1m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Net Income (Common)
ÂĄ533.9m
CAGR 3-Years
69%
CAGR 5-Years
90%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Net Income (Common)
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Net Income (Common)
ÂĄ12.7B
CAGR 3-Years
19%
CAGR 5-Years
25%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Net Income (Common)
ÂĄ711.5m
CAGR 3-Years
-12%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Net Income (Common)
ÂĄ2B
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Broncus Holding Corp
Glance View

Market Cap
242.5m HKD
Industry
Health Care

Broncus Holding Corp. engages in provision of interventional diagnosis and therapeutics solutions. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

Intrinsic Value
0.65 HKD
Undervaluation 29%
Intrinsic Value
Price
B

See Also

What is Broncus Holding Corp's Net Income (Common)?
Net Income (Common)
-28.1m USD

Based on the financial report for Dec 31, 2023, Broncus Holding Corp's Net Income (Common) amounts to -28.1m USD.

What is Broncus Holding Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
16%

Over the last year, the Net Income (Common) growth was 0%. The average annual Net Income (Common) growth rates for Broncus Holding Corp have been 16% over the past three years .

Back to Top